147 related articles for article (PubMed ID: 23695991)
1. The association of insulin resistance with serum osteoprotegerin in obese adolescents.
Suliburska J; Bogdanski P; Gajewska E; Kalmus G; Sobieska M; Samborski W
J Physiol Biochem; 2013 Dec; 69(4):847-53. PubMed ID: 23695991
[TBL] [Abstract][Full Text] [Related]
2. The relationship between insulin resistance assessed by HOMA-IR and serum osteoprotegerin levels in obesity.
Ugur-Altun B; Altun A; Gerenli M; Tugrul A
Diabetes Res Clin Pract; 2005 Jun; 68(3):217-22. PubMed ID: 15936463
[TBL] [Abstract][Full Text] [Related]
3. Circulating leptin and osteoprotegerin levels affect insulin resistance in healthy premenopausal obese women.
Ugur-Altun B; Altun A
Arch Med Res; 2007 Nov; 38(8):891-6. PubMed ID: 17923273
[TBL] [Abstract][Full Text] [Related]
4. Osteoprotegerin increases parallel to insulin resistance in obese adolescents.
Kotanidou EP; Kotanidis CP; Giza S; Serbis A; Tsinopoulou VR; Karalazou P; Tzimagiorgis G; Galli-Tsinopoulou A
Endocr Res; 2019; 44(1-2):9-15. PubMed ID: 29877745
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of selected serum mineral concentrations and their association with insulin resistance in obese adolescents.
Suliburska J; Cofta S; Gajewska E; Kalmus G; Sobieska M; Samborski W; Krejpcio Z; Drzymala-Czyz S; Bogdanski P
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2396-400. PubMed ID: 24065235
[TBL] [Abstract][Full Text] [Related]
6. Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects.
Ashley DT; O'Sullivan EP; Davenport C; Devlin N; Crowley RK; McCaffrey N; Moyna NM; Smith D; O'Gorman DJ
Metabolism; 2011 Jul; 60(7):994-1000. PubMed ID: 21087777
[TBL] [Abstract][Full Text] [Related]
7. Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study.
Gannagé-Yared MH; Yaghi C; Habre B; Khalife S; Noun R; Germanos-Haddad M; Trak-Smayra V
Eur J Endocrinol; 2008 Mar; 158(3):353-9. PubMed ID: 18299469
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin and insulin resistance in childhood obesity.
Panagopoulou P; Galli-Tsinopoulou A; Fleva A; Pavlitou-Tsiontsi E; Vavatsi-Christaki N; Nousia-Arvanitakis S
J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):356-62. PubMed ID: 18728534
[TBL] [Abstract][Full Text] [Related]
9. Osteoprotegerin expression and serum values in obese women with type 2 diabetes mellitus.
Rashad NM; El-Shal AS; Shalaby SM; Abdel-Nour HM; Sarhan WM
Mol Biol Rep; 2021 Nov; 48(11):7095-7104. PubMed ID: 34487291
[TBL] [Abstract][Full Text] [Related]
10. Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus.
Park JS; Cho MH; Nam JS; Yoo JS; Ahn CW; Cha BS; Kim KR; Lee HC
Eur J Endocrinol; 2011 Jan; 164(1):69-74. PubMed ID: 20961967
[TBL] [Abstract][Full Text] [Related]
11. Circulating osteoprotegerin in postmenopausal osteoporotic women: marker of impaired glucose regulation or impaired bone metabolism.
Mashavi M; Menaged M; Shargorodsky M
Menopause; 2017 Nov; 24(11):1264-1268. PubMed ID: 28697041
[TBL] [Abstract][Full Text] [Related]
12. Effect of Resistance Exercise on Serum Osteoprotegerin Levels and Insulin Resistance in Middle-Aged Women with Metabolic Syndrome.
Hur S; Cho SH; Song BK; Cho BJ
Med Sci Monit; 2018 Dec; 24():9385-9391. PubMed ID: 30582576
[TBL] [Abstract][Full Text] [Related]
13. Association of Osteoprotegerin with Obesity, Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Children.
Erol M; Bostan Gayret O; Tekin Nacaroglu H; Yigit O; Zengi O; Salih Akkurt M; Tasdemir M
Iran Red Crescent Med J; 2016 Nov; 18(11):e41873. PubMed ID: 28203453
[TBL] [Abstract][Full Text] [Related]
14. Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes.
Bernardi S; Fabris B; Thomas M; Toffoli B; Tikellis C; Candido R; Catena C; Mulatero P; Barbone F; Radillo O; Zauli G; Secchiero P
Mol Cell Endocrinol; 2014 Aug; 394(1-2):13-20. PubMed ID: 24998520
[TBL] [Abstract][Full Text] [Related]
15. Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction.
Pepene CE; Ilie IR; Marian I; Duncea I
Eur J Endocrinol; 2011 Jan; 164(1):61-8. PubMed ID: 20974706
[TBL] [Abstract][Full Text] [Related]
16. Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.
Vogeser M; König D; Frey I; Predel HG; Parhofer KG; Berg A
Clin Biochem; 2007 Sep; 40(13-14):964-8. PubMed ID: 17583689
[TBL] [Abstract][Full Text] [Related]
17. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
[TBL] [Abstract][Full Text] [Related]
18. The Bone Markers Sclerostin, Osteoprotegerin, and Bone-Specific Alkaline Phosphatase Are Related to Insulin Resistance in Children and Adolescents, Independent of Their Association with Growth and Obesity.
Stanik J; Kratzsch J; Landgraf K; Vogel M; Thiery J; Kiess W; Körner A
Horm Res Paediatr; 2019; 91(1):1-8. PubMed ID: 30904905
[TBL] [Abstract][Full Text] [Related]
19. The relationship between serum phosphate levels with childhood obesity and insulin resistance.
Celik N; Andiran N
J Pediatr Endocrinol Metab; 2011; 24(1-2):81-3. PubMed ID: 21528821
[TBL] [Abstract][Full Text] [Related]
20. The relationship between serum adiponectin, tumor necrosis factor-alpha, leptin levels and insulin sensitivity in childhood and adolescent obesity: adiponectin is a marker of metabolic syndrome.
Alikaşifoğlu A; Gönç N; Özön ZA; Sen Y; Kandemir N
J Clin Res Pediatr Endocrinol; 2009; 1(5):233-9. PubMed ID: 21274300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
